Published on 4/24/2020 in the Prospect News Structured Products Daily.
New Issue: Goldman prices $1.73 million leveraged basket-linked notes on 19 stocks
By Sarah Lizee
Olympia, Wash., April 24 – GS Finance Corp. priced $1.73 million of 0% leveraged notes due Oct. 20, 2021 linked to a basket of stocks, according to a 424B2 filing with the Securities and Exchange Commission.
The basket consists of Abbott Laboratories (5.49% weight), Adaptive Biotechnologies Corp. (4.58% weight), Alnylam Pharmaceuticals, Inc. (5.49% weight), Becton, Dickinson and Co. (5.49% weight), BioNTech SE (3% weight), Danaher Corp. (5.49% weight), Gilead Sciences, Inc. (5.49% weight), Grifols, SA (4.58% weight), Incyte Corp. (5.49% weight), Johnson & Johnson (5.49% weight), Laboratory Corp. of America Holdings (5.49% weight), Moderna, Inc. (5.49% weight), Novartis AG (5.49% weight), Quest Diagnostics Inc. (5.49% weight), Regeneron Pharmaceuticals, Inc. (5.49% weight), Sanofi (5.49% weight), Takeda Pharmaceutical Co. Ltd. (5.49% weight), Thermo Fisher Scientific Inc. (5.49% weight) and Vir Biotechnology, Inc. (5.49% weight).
If the basket return is positive, the payout at maturity will be par plus 1.5 times the basket return up to $1,192.75 for each $1,000 note.
If the basket decline, the payout will be par plus the return of the basket with full exposure to the decline.
Goldman Sachs & Co. LLC is the agent.
Issuer: | GS Finance Corp.
|
Guarantor: | Goldman Sachs Group, Inc.
|
Issue: | Leveraged notes
|
Underlying stocks: | Abbott Laboratories (5.49% weight), Adaptive Biotechnologies Corp. (4.58% weight), Alnylam Pharmaceuticals, Inc. (5.49% weight), Becton, Dickinson and Co. (5.49% weight), BioNTech SE (3% weight), Danaher Corp. (5.49% weight), Gilead Sciences, Inc. (5.49% weight), Grifols, SA (4.58% weight), Incyte Corp. (5.49% weight), Johnson & Johnson (5.49% weight), Laboratory Corp. of America Holdings (5.49% weight), Moderna, Inc. (5.49% weight), Novartis AG (5.49% weight), Quest Diagnostics Inc. (5.49% weight), Regeneron Pharmaceuticals, Inc. (5.49% weight), Sanofi (5.49% weight), Takeda Pharmaceutical Co. Ltd. (5.49% weight), Thermo Fisher Scientific Inc. (5.49% weight) and Vir Biotechnology, Inc. (5.49% weight)
|
Amount: | $1.73 million
|
Maturity: | Oct. 20, 2021
|
Coupon: | 0%
|
Price: | Par
|
Payout at maturity: | If basket return is positive, par plus 1.5 times the basket return up to $1,192.75 for each $1,000 note; otherwise, par plus the return of the basket with full exposure to the decline
|
Pricing date: | April 17
|
Settlement date: | April 24
|
Agent: | Goldman Sachs & Co. LLC
|
Fees: | 1.23%
|
Cusip: | 40056YZV9
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.